Cargando…

ARPP-19 Mediates Herceptin Resistance via Regulation of CD44 in Gastric Cancer

PURPOSE: As the first-line drug for treatment of HER2-positive metastatic gastric cancer (GC), Herceptin exhibits significant therapeutic efficacy. However, acquired resistance of Herceptin limits the therapeutic benefit of gastric cancer patients, in which the molecular mechanisms remain to be furt...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gao, Xiang, Lu, Changwen, Chen, Changyu, Sun, Kang, Liang, Qixin, Shuai, Jianfeng, Wang, Xiaoming, Xu, Yuxing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354958/ https://www.ncbi.nlm.nih.gov/pubmed/32753897 http://dx.doi.org/10.2147/OTT.S253841

Ejemplares similares

The Interaction Mechanism of Intrinsically Disordered PP2A Inhibitor Proteins ARPP-16 and ARPP-19 With PP2A
por: Thapa, Chandan, et al.
Publicado: (2021)

Increased ARPP-19 Expression Is Associated with Hepatocellular Carcinoma
por: Song, Haiyan, et al.
Publicado: (2014)

The study of the determinants controlling Arpp19 phosphatase-inhibitory activity reveals an Arpp19/PP2A-B55 feedback loop
por: Labbé, Jean Claude, et al.
Publicado: (2021)

(1)H, (13)C and (15)N NMR chemical shift assignments of cAMP-regulated phosphoprotein-19 and -16 (ARPP-19 and ARPP-16)
por: Thapa, Chandan J., et al.
Publicado: (2020)

ENSA and ARPP19 differentially control cell cycle progression and development
por: Hached, Khaled, et al.
Publicado: (2019)

Herceptin-Mediated Cardiotoxicity: Assessment by Cardiovascular Magnetic Resonance
por: Jiang, Jin, et al.
Publicado: (2022)

Psoriasis Induced by Trastuzumab (Herceptin®)
por: Kim, Dae Hun, et al.
Publicado: (2013)

The role of Herceptin in early breast cancer
por: Subramanian, Ashok, et al.
Publicado: (2008)

Herceptin in clinical use - early 2000
por: Vogel, CL
Publicado: (2000)

Mild hyperthermia influence on Herceptin(®) properties
por: Escoffre, Jean-Michel, et al.
Publicado: (2015)

Phosphorylation of ARPP19 by protein kinase A prevents meiosis resumption in Xenopus oocytes
por: Dupré, Aude, et al.
Publicado: (2014)

Specific Intracellular Uptake of Herceptin-Conjugated CdSe/ZnS Quantum Dots into Breast Cancer Cells
por: Han, Seung-Jin, et al.
Publicado: (2014)

Role of DARPP-32 and ARPP-21 in the Emergence of Temporal Constraints on Striatal Calcium and Dopamine Integration
por: Nair, Anu G., et al.
Publicado: (2016)

Transgenic models are predictive: the herceptin and flavopiridol experience
por: Schmidt, E
Publicado: (2003)

Herceptin clinical trials: past, present and future
por: Vogel, CL
Publicado: (2001)

The RNA-binding protein ARPP21 controls dendritic branching by functionally opposing the miRNA it hosts
por: Rehfeld, Frederick, et al.
Publicado: (2018)

Mechanism of ARPP21 antagonistic intron miR‐128 on neurological function repair after stroke
por: Chai, Zhaohui, et al.
Publicado: (2021)

Glycosylation of CD44 is implicated in CD44-mediated cell adhesion to hyaluronan
Publicado: (1996)

Combinatorial experimental protocols for Erbicin-derived immunoagents and Herceptin
por: De Lorenzo, C, et al.
Publicado: (2007)

Radiation Recall Reaction Induced by Adjuvant Trastuzumab (Herceptin)
por: Chung, Caroline, et al.
Publicado: (2009)

Ultrasound-triggered herceptin liposomes for breast cancer therapy
por: Elamir, Amal, et al.
Publicado: (2021)

Arpp19 Promotes Myc and Cip2a Expression and Associates with Patient Relapse in Acute Myeloid Leukemia
por: Mäkelä, Eleonora, et al.
Publicado: (2019)

MicroRNA-320a sensitizes tamoxifen-resistant breast cancer cells to tamoxifen by targeting ARPP-19 and ERRγ*
por: Lü, Mingrong, et al.
Publicado: (2015)

hsa_circ_0000520 influences herceptin resistance in gastric cancer cells through PI3K‐Akt signaling pathway
por: Lv, Xukun, et al.
Publicado: (2020)

Herceptin-sensitivity of HER2-transgenic mouse mammary tumors
por: Schwall, RH, et al.
Publicado: (2003)

Serological Her2/neu-determination in patients receiving Herceptin(®)
por: Thomas, A, et al.
Publicado: (2001)

Safety of trastuzumab (Herceptin(®)) during pregnancy: two case reports
por: Goodyer, Matthew J, et al.
Publicado: (2009)

Anticancer Effect of Metformin in Herceptin-Conjugated Liposome for Breast Cancer
por: Lee, Ji-Yeon, et al.
Publicado: (2019)

The Role of CD44 in the Pathogenesis, Diagnosis, and Therapy of Gastric Cancer
por: Jang, Byung Ik, et al.
Publicado: (2011)

Circular RNA circARPP21 Acts as a Sponge of miR-543 to Suppress Hepatocellular Carcinoma by Regulating LIFR
por: Gu, Yichao, et al.
Publicado: (2021)

Herceptin Resistance Database for Understanding Mechanism of Resistance in Breast Cancer Patients
por: Ahmad, Sahil, et al.
Publicado: (2014)

Delineation of anthracyclines and herceptin induced cardiotoxicity using contrast enhanced CMR
por: Hamirani, Yasmin S, et al.
Publicado: (2014)

Comparative Nonclinical Assessments of the Proposed Biosimilar PF-05280014 and Trastuzumab (Herceptin(®))
por: Hurst, Susan, et al.
Publicado: (2014)

Subcutaneous administration of rituximab (MabThera) and trastuzumab (Herceptin) using hyaluronidase
por: Shpilberg, O, et al.
Publicado: (2013)

Durable and Complete Response to Herceptin Monotherapy in Patients with Metastatic Gastroesophageal Cancer
por: Swofford, Brenen P., et al.
Publicado: (2017)

Cardiovascular Effects Mediated by HMMR and CD44
por: Jaskuła, Kinga, et al.
Publicado: (2021)

Drifts in ADCC-related quality attributes of Herceptin®: Impact on development of a trastuzumab biosimilar
por: Kim, Seokkyun, et al.
Publicado: (2017)

Herceptin Conjugates Linked by EDC Boost Direct Tumor Cell Death via Programmed Tumor Cell Necrosis
por: Hu, Jiemiao, et al.
Publicado: (2011)

CD44/CD24 Expression in recurrent gastric cancer: a retrospective analysis
por: Yong, Ching-Shya, et al.
Publicado: (2012)

Cancer Stem Cell Markers CD44, CD133 in Primary Gastric Adenocarcinoma
por: Nosrati, Anahita, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_gojnltdjdq02nc6nof0nuf6iqv